DPM3 Gene Glycosylation Disorder Type 1O Genetic Test
At DNA Labs UAE, we offer the DPM3 Gene Glycosylation Disorder Type 1O Genetic Test to help diagnose and manage this specific subtype of glycosylation disorder. This genetic test analyzes the DPM3 gene and other genes associated with glycosylation disorders using Next-Generation Sequencing (NGS) technology.
Test Details
The DPM3 gene encodes an enzyme called dolichyl-phosphate mannosyltransferase subunit 3, which is involved in the glycosylation process. Glycosylation disorders are genetic disorders that occur due to abnormalities in the glycosylation process, affecting various organs and systems in the body.
Symptoms and Diagnosis
DPM3 gene glycosylation disorder type 1O is characterized by intellectual disability, developmental delay, seizures, and other neurological symptoms. To diagnose this disorder, a patient’s clinical history is taken into consideration. A genetic counseling session is conducted to draw a pedigree chart of affected family members, which helps in understanding the inheritance pattern and identifying individuals at risk.
Test Components and Price
- Components: DPM3 gene and other genes associated with glycosylation disorders
- Price: 4400.0 AED
Sample Condition and Report Delivery
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
Method and Test Type
- Method: NGS Technology
- Test Type: Metabolic Disorders
Doctor and Test Department
- Doctor: General Physician
- Test Department: Genetics
Importance of Genetic Counseling
Genetic counseling is an essential part of the testing process for DPM3 gene glycosylation disorder type 1O. It helps individuals understand the inheritance pattern, identify family members at risk, and make informed decisions about family planning and genetic testing.
By undergoing the DPM3 Gene Glycosylation Disorder Type 1O Genetic Test, healthcare professionals can diagnose this disorder accurately and provide appropriate management and treatment options for affected individuals.
Test Name | DPM3 Gene Glycosylation disorder type 1O Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for DPM3 Gene Glycosylation disorder type 1O NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1O |
Test Details |
The DPM3 gene is responsible for encoding an enzyme called dolichyl-phosphate mannosyltransferase subunit 3. This enzyme is involved in the glycosylation process, which is the attachment of sugar molecules to proteins and lipids. Glycosylation disorders are a group of genetic disorders that result from abnormalities in the glycosylation process. These disorders can affect various organs and systems in the body, leading to a wide range of symptoms and complications. DPM3 gene glycosylation disorder type 1O is a specific subtype of glycosylation disorder caused by mutations in the DPM3 gene. This disorder is characterized by intellectual disability, developmental delay, seizures, and other neurological symptoms. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the analysis of multiple genes simultaneously. It uses high-throughput sequencing technologies to rapidly sequence large amounts of DNA. NGS genetic testing can be used to identify mutations in the DPM3 gene and other genes associated with glycosylation disorders. By performing an NGS genetic test, healthcare professionals can diagnose DPM3 gene glycosylation disorder type 1O and provide appropriate management and treatment options for affected individuals. |